| scholarly article | Q13442814 |
| P50 | author | Jonathan R Lindner | Q89706631 |
| Alexander Klibanov | Q4719325 | ||
| P2093 | author name string | Brandenburger GH | |
| Coggins MP | |||
| Kaul S | |||
| Ley K | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| microbubble | Q6839290 | ||
| P304 | page(s) | 668-675 | |
| P577 | publication date | 2000-02-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Microbubble persistence in the microcirculation during ischemia/reperfusion and inflammation is caused by integrin- and complement-mediated adherence to activated leukocytes | |
| P478 | volume | 101 |
| Q30412053 | A comparative evaluation of ultrasound molecular imaging, perfusion imaging, and volume measurements in evaluating response to therapy in patient-derived xenografts |
| Q55088792 | Administration of Oxygen Ultra-Fine Bubbles Improves Nerve Dysfunction in a Rat Sciatic Nerve Crush Injury Model. |
| Q34412613 | Albumin-based Microbubbles Bind Up-regulated Scavenger Receptors following Vascular Injury |
| Q38831825 | Assessment of Molecular Acoustic Angiography for Combined Microvascular and Molecular Imaging in Preclinical Tumor Models |
| Q27021416 | Cardiovascular molecular imaging with contrast ultrasound: principles and applications. |
| Q47094849 | Cationic gas-filled microbubbles for ultrasound-based nucleic acids delivery |
| Q34083722 | Complement activation in heart diseases. Role of oxidants |
| Q47928167 | Contrast echocardiography: potential for the in-vivo study of pediatric myocardial preservation |
| Q37385650 | Contrast ultrasound molecular imaging of inflammation in cardiovascular disease |
| Q30309910 | Contrast ultrasound targeted drug and gene delivery: an update on a new therapeutic modality |
| Q37657893 | Critical appraisal of targeted ultrasound contrast agents for molecular imaging in large arteries |
| Q30559110 | Detection of antecedent myocardial ischemia with multiselectin molecular imaging |
| Q30408017 | Detection of high-risk atherosclerotic plaques with ultrasound molecular imaging of glycoprotein IIb/IIIa receptor on activated platelets |
| Q30310273 | Detection of inflamed plaques with contrast ultrasound |
| Q92396758 | Development of a Translatable Ultrasound Molecular Imaging Agent for Inflammation |
| Q30457849 | Effect of surface architecture on in vivo ultrasound contrast persistence of targeted size-selected microbubbles |
| Q42849488 | Effects of Microbubbles and Ultrasound on the Microcirculation: Observation on the Hamster Cheek Pouch |
| Q36568524 | Evaluating the 'no reflow' phenomenon with myocardial contrast echocardiography |
| Q26781564 | Evolution of contrast agents for ultrasound imaging and ultrasound-mediated drug delivery |
| Q30310252 | Evolving applications for contrast ultrasound |
| Q30470286 | Formulation and characterization of echogenic lipid-Pluronic nanobubbles |
| Q30473050 | Future applications of contrast ultrasound |
| Q50866246 | Gaseous micro-emboli activity during cardiopulmonary bypass in adults: pulsatile flow versus nonpulsatile flow. |
| Q44927479 | Imaging of angiogenesis using Cadence contrast pulse sequencing and targeted contrast agents |
| Q33697215 | Imaging of atherosclerosis |
| Q51817182 | In Search of the Optimal Heart Perfusion Ultrasound Imaging Platform. |
| Q24804921 | In vivo imaging approaches in animal models of rheumatoid arthritis |
| Q30309873 | Influence of microbubble surface charge on capillary transit and myocardial contrast enhancement |
| Q36095769 | Ischemic post-conditioning attenuates renal ischemic reperfusion injury via down-regulation of toll-like receptor 4 in diabetic rats |
| Q84791739 | Late-phase detection of recent myocardial ischaemia using ultrasound molecular imaging targeted to intercellular adhesion molecule-1 |
| Q35605546 | Leukocyte recruitment and acute renal failure |
| Q35475925 | Lymphatic imaging: focus on imaging probes |
| Q90346534 | Microbubble Formulations: Synthesis, Stability, Modeling and Biomedical Applications |
| Q30367059 | Microbubble gas volume: A unifying dose parameter in blood-brain barrier opening by focused ultrasound |
| Q30433669 | Microbubbles in medical imaging: current applications and future directions |
| Q52694389 | Molecular Imaging in Drug Discovery and Development. |
| Q30473382 | Molecular Imaging of Activated von Willebrand Factor to Detect High-Risk Atherosclerotic Phenotype |
| Q42121924 | Molecular and clinical aspects of targeting the VEGF pathway in tumors. |
| Q30461248 | Molecular imaging of cardiovascular disease using ultrasound |
| Q37511734 | Molecular imaging of cardiovascular disease with contrast-enhanced ultrasonography |
| Q30457844 | Molecular imaging of disease with targeted contrast ultrasound imaging |
| Q36617730 | Molecular imaging of inflammation and platelet adhesion in advanced atherosclerosis effects of antioxidant therapy with NADPH oxidase inhibition. |
| Q37752025 | Molecular imaging with contrast enhanced ultrasound |
| Q30312262 | Molecular imaging with contrast ultrasound and targeted microbubbles |
| Q83669147 | Molecular imaging with targeted contrast ultrasound |
| Q30475428 | Molecular imaging: spawning a new melting-pot for biomedical imaging |
| Q37777365 | Molecular ultrasound imaging and its potential for paediatric radiology |
| Q45286576 | Novel site-specific systemic delivery of Rapamycin with perfluorobutane gas microbubble carrier reduced neointimal formation in a porcine coronary restenosis model |
| Q42332001 | Novel ways to noninvasively detect inflammation of the myocardium: contrast-enhanced MRI and myocardial contrast echocardiography |
| Q28353954 | Optical and acoustical dynamics of microbubble contrast agents inside neutrophils |
| Q52819096 | Oxygen ultra-fine bubbles water administration prevents bone loss of glucocorticoid-induced osteoporosis in mice by suppressing osteoclast differentiation. |
| Q37117987 | Pathophysiology and clinical implications of microbubbles during hemodialysis |
| Q90745600 | Persistent Enhancement on Contrast-Enhanced Ultrasound Studies of Severe Crohn's Disease: Stuck Bubbles? |
| Q33268457 | Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells |
| Q47446913 | Polymer vesicles in vivo: correlations with PEG molecular weight |
| Q30465292 | Preclinical Lymphatic Imaging |
| Q30424128 | Renal retention of lipid microbubbles: a potential mechanism for flank discomfort during ultrasound contrast administration |
| Q92396778 | Seeing the Invisible-Ultrasound Molecular Imaging |
| Q60302167 | Selective infarct zone imaging with intravenous acoustically activated droplets |
| Q45858068 | Sonoporation, drug delivery, and gene therapy |
| Q44776900 | Systemic targeted delivery of antisense with perflourobutane gas microbubble carrier reduced neointimal formation in the porcine coronary restenosis model |
| Q37787083 | Target: ligand interactions of the vascular endothelium. Implications for molecular imaging in inflammation |
| Q30734358 | Targeted imaging using ultrasound |
| Q30472688 | Targeted renal therapies through microbubbles and ultrasound☆ |
| Q30312032 | Targeted tissue transfection with ultrasound destruction of plasmid-bearing cationic microbubbles |
| Q52814976 | The influence of intercalating perfluorohexane into lipid shells on nano and microbubble stability. |
| Q30464013 | The role of poly(ethylene glycol) brush architecture in complement activation on targeted microbubble surfaces |
| Q37064982 | The role of ultrasound and magnetic resonance in local drug delivery |
| Q35968117 | The role of ultrasound in molecular imaging |
| Q47966546 | Therapeutic application of contrast ultrasound in ST elevation myocardial infarction: Role in coronary thrombosis and microvascular obstruction. |
| Q30440590 | Ultrasound Contrast Agents in the Study of Kidney Function in Health and Disease |
| Q44763975 | Ultrasound contrast agents can influence the respiratory burst activity of human neutrophil granulocytes |
| Q28087550 | Ultrasound imaging for risk assessment in atherosclerosis |
| Q53286813 | Ultrasound inflammation imaging in rats with myocardial ischemia-reperfusion: evaluation by non-specific targeted contrast microbubbles. |
| Q37424337 | Ultrasound molecular imaging |
| Q37506868 | Ultrasound molecular imaging of atherosclerosis |
| Q89706634 | Ultrasound molecular imaging: insights into cardiovascular pathology |
| Q36640312 | Ultrasound-induced cavitation: applications in drug and gene delivery |
| Q27026689 | Ultrasound-mediated targeted drug delivery: recent success and remaining challenges |
| Q51762401 | Use of intravital microscopy to study the microvascular behavior of microbubble-based ultrasound contrast agents. |
| Q42605406 | Visualization of risk-area myocardium as a high-intensity, hyperenhanced "hot spot" by myocardial contrast echocardiography following coronary reperfusion: quantitative analysis |
| Q86386609 | [Molecular ultrasound imaging: Clinical applications] |
| Q81778491 | [Possible target specific molecular imaging with ultrasound contrast agents] |
| Q81312416 | [Ultrasound contrast agents. Pharmaceutical drug safety and bioeffects] |
Search more.